IBB vs VGIT
iShares Biotechnology ETF vs Vanguard Intermediate-Term Treasury ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
VGIT—
Vanguard Intermediate-Term Treasury ETF
Intermediate-term US Treasuries (3–10 years).
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | VGIT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
Holdings data unavailable for IBB.
VGIT top holdings
Holdings data unavailable for VGIT.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About VGIT
VGIT (Vanguard Intermediate-Term Treasury ETF) is Intermediate-term US Treasuries (3–10 years).